LLY is currently developing the following drugs: Imlunestrant, Imlunestrant + Goserelin, Tamoxifen 20 Mg, Pre-Filled Syringe, Eloralintide, Ly4213663. These drug candidates are in various stages of clinical development as the company works toward FDA approval.